Efficacy of low-dose versus high-dose cyclophosphamide in lupus nephritis: comment on the article by Houssiau et al

被引：1
|
作者：
Block, JA [1 ]
机构：
[1] Rush Med Coll, Chicago, IL 60612 USA
来源：
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 05期
关键词：
D O I：
10.1002/art.10967
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1466 / 1466
页数：1
相关论文
共 50 条
  • [1] Immunosuppressive therapy in lupus nephritis -: The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide
    Houssiau, FA
    Vasconcelos, C
    D'Cruz, D
    Sebastiani, GD
    Garrido, ED
    Danieli, MG
    Abramovicz, D
    Blockmans, D
    Mathieu, A
    Direskeneli, H
    Galeazzi, M
    Gül, A
    Levy, Y
    Petera, P
    Popovic, R
    Petrovic, R
    Sinico, RA
    Cattaneo, R
    Font, J
    Depresseux, G
    Cosyns, JP
    Cervera, R
    ARTHRITIS AND RHEUMATISM, 2002, 46 (08): : 2121 - 2131
  • [2] Comparative efficacy and safety of low-dose and high-dose cyclophosphamide as induction therapy for lupus nephritis: a network meta-analysis
    Bae, S-C
    Lee, Y. H.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2019, 78 (05): : 467 - 473
  • [3] This house believes that low-dose intravenous cyclophosphamide is superior to standard high-dose regimes for treatment of lupus nephritis
    Gorman, C
    Bhatia, A
    Rahman, A
    RHEUMATOLOGY, 2005, 44 (03) : 398 - 401
  • [4] Comparison of Lupus Nephritis Induction Therapy with Cyclophosphamide High Dose Versus Low Dose
    Valim, Juliana
    Lima, Veronica
    Guimardes, Fernanda
    Chaer, Fernanda
    Souza, Branca
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [5] Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: a single center study
    Sonal Mehra
    Jignesh B. Usdadiya
    Vikramraj K. Jain
    Durga Prasanna Misra
    Vir Singh Negi
    Rheumatology International, 2018, 38 : 557 - 568
  • [6] Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: a single center study
    Mehra, Sonal
    Usdadiya, Jignesh B.
    Jain, Vikramraj K.
    Misra, Durga Prasanna
    Negi, Vir Singh
    RHEUMATOLOGY INTERNATIONAL, 2018, 38 (04) : 557 - 568
  • [7] Synchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis
    Danieli, MG
    Palmieri, C
    Salvi, A
    Refe, MC
    Strusi, AS
    Danieli, G
    JOURNAL OF CLINICAL APHERESIS, 2002, 17 (02) : 72 - 77
  • [8] High-dose low-dose
    deVries, EGE
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 599 - 599
  • [9] Vasopressin Versus Terlipressin and Low-Dose Versus High-Dose Steroids
    Mentzelopoulos, Spyros D.
    Vrettou, Charikleia S.
    Zakynthinos, Spyros G.
    PEDIATRIC CRITICAL CARE MEDICINE, 2014, 15 (08) : 794 - 795
  • [10] High- and low-dose cyclophosphamide in Egyptian lupus nephritis patients: a multicenter retrospective analysis
    Elaziz, Mohamed Momtaz A.
    Gamal, Sherif M.
    Fayed, Ahmed
    Abu-Zaid, Mohammed Hassan
    Ghoniem, Shada A.
    Teleb, Doaa A.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2024, 83 (SUPPL 1): : 115 - 123
12345